Involvement and Clinical Aspects of MicroRNA in Osteosarcoma
AbstractOsteosarcoma (OS) is the most common primary bone cancer in children and adolescents, but its pathogenesis has been difficult to establish because of its well-known heterogeneous nature. OS has been associated with genetic and cytogenetic abnormalities, which include function-impairing mutations in tumor suppressors and the activation of oncogenes. OS tumorigenesis has been linked to alterations of several genes characterized by a high level of genetic instability and recurrent DNA amplifications and deletions. MicroRNAs (miRNAs), 18–25-nucleotide noncoding RNAs, are critical for various biological processes like differentiation, cell growth and cell death. Dysregulation of miRNA expression leads to phenotypic and genotypic changes in cells, which leads to cancer. Studies on miRNAs have initiated a significant effect in both diagnosis and treatment of cancer. This review focuses on the current knowledge of clinical applications of miRNAs for the better diagnosis and management of OS. View Full-Text
Share & Cite This Article
Ram Kumar, R.M.; Boro, A.; Fuchs, B. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma. Int. J. Mol. Sci. 2016, 17, 877.
Ram Kumar RM, Boro A, Fuchs B. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma. International Journal of Molecular Sciences. 2016; 17(6):877.Chicago/Turabian Style
Ram Kumar, Ram M.; Boro, Aleksandar; Fuchs, Bruno. 2016. "Involvement and Clinical Aspects of MicroRNA in Osteosarcoma." Int. J. Mol. Sci. 17, no. 6: 877.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.